Anti-IGF-1 receptor (IGF-1R) monoclonal antibodies (mAbs) were developed for clinical use in treating advanced stage cancers 22,23,24 , including Ganitumab, which remains under investigation as a combination therapy in clinical trials targeting Rhabdomyosarcoma (NCT03041701) and Ewing Sarcoma (NCT02306161), for which it recently received orphan drug status
BPC-157: Bro-Science or Breakthrough
Legal considerations Peptide legality varies by jurisdiction and intended use
Ready to take the drama out of your digestion
Here all known effects of GHK-Cu were brought together into a single coherent mechanistic model
Emerging research highlights the role of Mn beyond individual organ systems, revealing coordinated interactions between the liver, intestines, and brain